{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:03:07Z","timestamp":1791446587805,"version":"4.3.3"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"crossref","award":["113611"],"award-info":[{"award-number":["113611"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.bbmt.2015.10.009","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T07:50:50Z","timestamp":1445759450000},"page":"710-716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":199,"title":["Fluticasone, Azithromycin, and Montelukast Treatment for\u00a0New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"22","author":[{"given":"Kirsten M.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Shing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iskra","family":"Pusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madan","family":"Jagasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent T.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Pidala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason W.","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Jacobsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Z.","family":"Pavletic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry E.","family":"Storer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.D.","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2600-6390","authenticated-orcid":false,"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2015.10.009_bib1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.2009.1018","article-title":"Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation","volume":"302","author":"Williams","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2015.10.009_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbmt.2013.11.025","article-title":"Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease","volume":"20","author":"Palmer","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib3","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.bbmt.2012.03.008","article-title":"Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation","volume":"18","author":"Sengsayadeth","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1 Suppl","key":"10.1016\/j.bbmt.2015.10.009_bib4","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.bbmt.2009.11.002","article-title":"Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease","volume":"16","author":"Chien","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib5","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbmt.2010.11.018","article-title":"Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation","volume":"17","author":"Au","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/bmt.2012.241","article-title":"Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis","volume":"48","author":"Bergeron","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.bbmt.2014.02.011","article-title":"Screening with spirometry is a useful predictor of later development of noninfectious pulmonary syndromes in patients undergoing allogeneic stem cell transplantation","volume":"20","author":"Thompson","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1164\/ajrccm.159.3.9607099","article-title":"Analysis of risk factors for the development of bronchiolitis obliterans syndrome","volume":"159","author":"Husain","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bbmt.2015.10.009_bib9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1513\/pats.200601-007AW","article-title":"Mechanisms of airway obliteration after lung transplantation","volume":"3","author":"Nicod","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.bbmt.2015.10.009_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-6143.2004.00650.x","article-title":"HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction","volume":"5","author":"Girnita","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1164\/rccm.200702-335OC","article-title":"A\u00a0new murine model for bronchiolitis obliterans post-bone marrow transplant","volume":"176","author":"Panoskaltsis-Mortari","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bbmt.2015.10.009_bib12","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2011-07-364414","article-title":"Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans","volume":"119","author":"Srinivasan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.10.009_bib13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.7326\/0003-4819-111-5-368","article-title":"Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course","volume":"111","author":"Clark","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2015.10.009_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1083-8791(03)00242-8","article-title":"Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes","volume":"9","author":"Dudek","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/bmt.2009.33","article-title":"Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children","volume":"44","author":"Nishio","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/bmt.2010.152","article-title":"Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT","volume":"46","author":"Lucid","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib17","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/bmt.2011.35","article-title":"Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD","volume":"46","author":"Hildebrandt","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report","volume":"201","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib20","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.bbmt.2014.02.026","volume":"20","author":"Yanik","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib21","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/bmt.2011.1","article-title":"Effects of azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT\u2013a randomized double-blinded placebo-controlled study","volume":"46","author":"Lam","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib22","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1164\/rccm.201410-1818OC","article-title":"Budesonide\/formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation","volume":"191","author":"Bergeron","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bbmt.2015.10.009_bib23","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.bbmt.2012.11.087","article-title":"Interim analysis of a phase II trial of montelukast for the treatment of bronchiolitis obliterans syndrome after HSCT reveal immunobiology of disease","volume":"19","author":"Williams","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib24","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/bmt.2010.311","article-title":"Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients","volume":"46","author":"Norman","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib25","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1183\/09031936.05.00020804","article-title":"Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study","volume":"25","author":"Khalid","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bbmt.2015.10.009_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bmt.1705877","article-title":"Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation","volume":"41","author":"Bashoura","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1164\/rccm.200212-1424BC","article-title":"Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study","volume":"168","author":"Gerhardt","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bbmt.2015.10.009_bib28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.tp.0000295981.84633.bc","article-title":"Long-term azithromycin for\u00a0bronchiolitis obliterans syndrome after lung transplantation","volume":"85","author":"Gottlieb","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2015.10.009_bib29","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1164\/rccm.200411-1537OC","article-title":"Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome","volume":"172","author":"Yates","year":"2005","journal-title":"Am J\u00a0Respir Crit Care Med"},{"key":"10.1016\/j.bbmt.2015.10.009_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1084\/jem.20042481","article-title":"BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation","volume":"202","author":"Medoff","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2015.10.009_bib31","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1172\/JCI118612","article-title":"Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis","volume":"97","author":"Wilborn","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bbmt.2015.10.009_bib32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.tp.0000255575.03795.df","article-title":"Sparing effect by montelukast treatment for chronic graft versus host disease: a pilot study","volume":"83","author":"Or","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2015.10.009_bib33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bmt.1705637","article-title":"Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation","volume":"39","author":"Bergeron","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib34","first-page":"31","article-title":"Bronchoalveolar lavage cellular profiles in lung transplantation: the effect of inhaled corticosteroids","volume":"5","author":"Whitford","year":"2000","journal-title":"Ann Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib35","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/00007890-200206150-00016","article-title":"Addition of inhaled corticosteroids to systemic immunosuppression after lung transplantation: a double-blind, placebo-controlled trial","volume":"73","author":"Whitford","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2015.10.009_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/bmt.2009.106","article-title":"Macrolides in the treatment of bronchiolitis obliterans in allograft recipients","volume":"44","author":"Maimon","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib37","first-page":"659","article-title":"Reference spirometric values using techniques and equipment that meet ATS recommendations","volume":"123","author":"Crapo","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.bbmt.2015.10.009_bib38","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.bbmt.2011.11.031","article-title":"Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation","volume":"18","author":"Yanik","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib39","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01.jom.0000128159.09520.2a","article-title":"Repeated measures of FEV1 over six to twelve months: what change is abnormal?","volume":"46","author":"Wang","year":"2004","journal-title":"J\u00a0Occup Environ Med"},{"key":"10.1016\/j.bbmt.2015.10.009_bib40","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.bbmt.2015.02.025","article-title":"Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report","volume":"21","author":"Lee","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.bmt.1705434","article-title":"Quality of life associated with acute and chronic graft-versus-host disease","volume":"38","author":"Lee","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib42","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1053\/bbmt.2002.v8.pm12234170","article-title":"Development and validation of a scale to measure symptoms of chronic graft-versus-host disease","volume":"8","author":"Lee","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib43","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1183\/09031936.95.08040551","article-title":"Post-transplant obstructive lung disease (\u201cbronchiolitis obliterans\u201d): a clinical comparative study of bone marrow and lung transplant patients","volume":"8","author":"Philit","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bbmt.2015.10.009_bib44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.bmt.1700894","article-title":"Long-term follow-up of immunosuppressive treatment for obstructive airways disease after allogeneic bone marrow transplantation","volume":"20","author":"Sanchez","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib45","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.200212-1468OC","article-title":"Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation","volume":"168","author":"Chien","year":"2003","journal-title":"Am J\u00a0Respir Crit Care Med"},{"key":"10.1016\/j.bbmt.2015.10.009_bib46","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1182\/blood.V72.2.621.621","article-title":"Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG","volume":"72","author":"Holland","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.10.009_bib47","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-126-3-199702010-00002","article-title":"Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation","volume":"126","author":"Duell","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2015.10.009_bib48","first-page":"169","article-title":"Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation","volume":"16","author":"Curtis","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/sj.bmt.1704377","article-title":"Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation","volume":"33","author":"Marras","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.10.009_bib50","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbmt.2006.01.008","article-title":"Measuring therapeutic response in\u00a0chronic graft-versus-host disease: National Institutes of Health\u00a0Consensus Development Project on Criteria for Clinical Trials\u00a0in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report","volume":"12","author":"Pavletic","year":"2006","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115006795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115006795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:55:08Z","timestamp":1761058508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879115006795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1083879115006795"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.10.009","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluticasone, Azithromycin, and Montelukast Treatment for\u00a0New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}